医師の一分

アクセスカウンタ

zoom RSS 黄色ブドウ球菌は人のヘモグロビンを好む/多剤耐性菌 MRSA

<<   作成日時 : 2010/12/19 22:55   >>

なるほど(納得、参考になった、ヘー) ブログ気持玉 1 / トラックバック 0 / コメント 0

黄色ブドウ球菌は人のヘモグロビンを好む
画像 致死性の病気を引き起こす黄色ブドウ球菌がなぜ動物ではなく人間を攻撃するかという問題の答えがわかったという。1年に米国人10万人がこの細菌のために死亡しており最も多い。
 水曜日に発表されたバンダービルト大の研究によれば、ブドウ球菌はヒトのヘモグロビンの特定の部位に狙いを定めて檻のような分子を破裂させて中で鉄を食べることができるように進化してきたという。ブドウ球菌に抵抗力がある人々は、攻撃に耐えられるように、細菌が捜すヘモグロビン領域を調節するわずかな遺伝変異を持つかもしれないという。30%の人は感染徴候なく鼻腔内にブドウ状球菌を持っている。
 ブドウ球菌は心臓・皮膚・軟組織感染の最も多い原因菌で、肺炎の原因ともなる。どのような組織内に住み着くこともできる。
 全ての生物同様、鉄を必要とするが、この細菌は赤血球を破裂させて鉄をつかみとることを発見した。さらに、特定のヘモグロビンを好む。動物の血液のなかで、高等動物ほど好む傾向がわかった。特にヒトのヘモグロビンの蛋白のある部分をつかむ傾向が強く、ヒトのヘモグロビンではマウスの10倍も細菌が成長する。
 マウスを使ったブドウ球菌感染研究はなかなかうまくいかない理由がわかり、ヒトのヘモグロビンを持ったマウスを使う必要がある。
 なぜ1/3の人は鼻にブドウ球菌を常在し、一方では致死性の感染に至るのだろうか?
 ブドウ球菌感受性はヘモグロビン遺伝子の変異にその鍵があるのではないか?

----------------------------------------------------
Staph’s Trail Points to Human Susceptibilities
By GINA KOLATA
Published: December 15, 2010
http://www.nytimes.com/2010/12/16/science/16staph.html

Scientists have finally found an answer to one of the great mysteries about the most deadly bacteria, Staphylococcus aureus ― why it attacks primarily humans and not animals. And they now have an idea of why some humans are particularly susceptible to these bacteria that kill 100,000 Americans a year, far more than any other microbe.

In a study released on Wednesday, researchers at Vanderbilt University report that staph evolved to zero in on particular regions of human hemoglobin so it could burst the cagelike molecule and feed on the iron inside. People who are resistant to staph, they suspect, might have slight genetic variations that tweak the hemoglobin regions the bacteria seek, making them impervious to the attack.

The work is part of a more general look at genes and disease. With new tools to look in detail at slight genetic variations, researchers are asking why some people get some diseases and others do not and why some die from diseases that others almost shrug off. With staph, for instance, 30 percent of the population harbors the bacteria in their noses, with no signs of infection.

Staph experts say the discovery, published in the Dec. 16 issue of Cell Host & Microbe, answers a lot of questions about the bacteria and shows them new directions for research.

“It’s terrific work,” said Frank DeLeo, acting chief of human bacterial pathogenesis at the National Institute of Allergy and Infectious Diseases. “It really is moving the field forward.”

The work began in 2002 when Eric P. Skaar was a postdoctoral fellow and fascinated by staph.

“Staph is the worst infectious threat to public health,” he said. “It is the No. 1 cause of heart infections and skin infections, the No. 1 cause of soft tissue infections. It is a big cause of pneumonia. It is the No. 1 hospital acquired infection.”

The bacteria can take up residence in any tissue of the body, he added.

Staph, he said, “is sort of a creepy bug.”

But it, like all organisms, needs iron, and Dr. Skaar wondered how it got it. The answer, he discovered, is that the bacteria “pop open red blood cells and grab the iron.”

Now, as an associate professor at Vanderbilt, Dr. Skaar asked a question no one had thought to ask before: Do the bacteria like some hemoglobins more than others?

He grew staph in the lab, giving them blood from different animals, from mice to baboons to humans. Staph definitely preferred human blood, he reported in the new paper, but there also was a definite trend, the higher up the evolutionary scale an animal was, the more the bacteria liked its blood.

Then Dr. Skaar and his colleagues found the protein on staph that attaches to hemoglobin and discovered that it grabs onto segments of the blood protein that are specifically in humans. It can attach to similar segments in animal hemoglobins, but less avidly.

Finally, the researchers infected two strains of mice. One was normal lab mice, with normal mouse hemoglobin. The other had half human hemoglobin and half mouse hemoglobin. The strain with human and mouse hemoglobin had 10 times as much bacteria growing in its organs.

That explains why it has been so frustrating to study staph infections in mice, said Mark S. Smeltzer of the University of Arkansas for Medical Sciences. Researchers use mice, which are cheap and readily available, to study treatments and vaccines for staph. But it has been so hard to infect them ― scientists have to inject them with so many bacteria, Dr. Smeltzer said, that “to my mind it is unrealistic.”

It was just so much more than were required for many, if not most, infections of humans, he explained. The new study explained why and suggested a way around the problem ― using mice with human hemoglobin ― he added.

But, for Dr. Skaar, the result also suggested an answer to one of the most pressing questions about staph infections in people: Why do one-third of the population have the bacteria in their noses and not get sick while, for others, a staph infection can be lethal?

“In my opinion, that is the most important question in Staph aureus biology right now,” Dr. Skaar said.

His work, he said, suggests that there are genetic factors that determine susceptibility to infection between species. Are there also genetic factors that determine susceptibility within a species, the human species?

He has a way of finding out. There are well-characterized minor genetic differences in hemoglobins among different people. And Vanderbilt Medical Center has a gene bank with the DNA of thousands of its patients. Dr. Skaar is using that gene bank now to look at the hemoglobin genes of all the patients who had staph infections and compare them with the gene sequences of patients who were not infected. He expects that if there are variations among human hemoglobins that determine susceptibility to staph, he is likely to find them.

His hope, he said, is that in the future a patient will come to a hospital and, as part of a routine work-up, doctors will determine from the person’s hemoglobin whether to worry about staph. Those who are susceptible would get intravenous antibiotics before risky procedures like surgery.

“That’s the most exciting possibility,” Dr. Skaar said. “Just knowing you were more susceptible would be very valuable.”

-----------------------------------------------------
Specificity for Human Hemoglobin Enhances Staphylococcus aureus Infection

Cell Host & Microbe, Volume 8, Issue 6, 544-550, 16 December 2010
Copyright (c) 2010 Elsevier Inc. All rights reserved.
10.1016/j.chom.2010.11.002


Authors
Gleb Pishchany, Amanda L. McCoy, Victor J. Torres, Jens C. Krause, James E. Crowe, Mary E. Fabry, Eric P. Skaarsend emailSee Affiliations

* Hint: Rollover Authors and Affiliations
*

Department of Microbiology and Immunology, Vanderbilt University Medical School, Nashville, TN 37232, USA Department of Pediatrics, Vanderbilt University Medical School, Nashville, TN 37232, USA Division of Hematology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA Corresponding author Present address: Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA

* Highlights
* Staphylococcus aureus preferentially binds hemoglobin derived from humans (hHb)
* S. aureus IsdB binds hHb with a stronger affinity than mouse Hb
* Increased binding of hHb facilitates iron acquisition by S. aureus
* Increased iron availability exacerbates S. aureus infection in hHb-expressing mice

Summary

Iron is required for bacterial proliferation, and Staphylococcus aureus steals this metal from host hemoglobin during invasive infections. This process involves hemoglobin binding to the cell wall of S. aureus, heme extraction, passage through the cell envelope, and degradation to release free iron. Herein, we demonstrate an enhanced ability of S. aureus to bind hemoglobin derived from humans as compared to other mammals. Increased specificity for human hemoglobin (hHb) translates into an improved ability to acquire iron and is entirely dependent on the staphylococcal hemoglobin receptor IsdB. This feature affects host-pathogen interaction as demonstrated by the increased susceptibility of hHb-expressing mice to systemic staphylococcal infection. Interestingly, enhanced utilization of human hemoglobin is not a uniform property of all bacterial pathogens. These results suggest a step in the evolution of S. aureus to better colonize the human host and establish hHb-expressing mice as a model of S. aureus pathogenesis.

テーマ

関連テーマ 一覧


月別リンク

ブログ気持玉

クリックして気持ちを伝えよう!
ログインしてクリックすれば、自分のブログへのリンクが付きます。
→ログインへ
気持玉数 : 1
なるほど(納得、参考になった、ヘー)

トラックバック(0件)

タイトル (本文) ブログ名/日時

トラックバック用URL help


自分のブログにトラックバック記事作成(会員用) help

タイトル
本 文

コメント(0件)

内 容 ニックネーム/日時

コメントする help

ニックネーム
本 文
黄色ブドウ球菌は人のヘモグロビンを好む/多剤耐性菌 MRSA 医師の一分/BIGLOBEウェブリブログ
文字サイズ:       閉じる